SL
ELV icon

Summitry LLC’s Elevance Health ELV Stock Holding History

Summitry LLC’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Buy
+661
New +$245K 0.01% 278

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Summitry LLC's ELV Position: Q2 2026 in Review

Summitry LLC opened a new position in Elevance Health (ELV) in Q2 2026: 661 shares worth $256K. The stake represents 0.01% of the portfolio and ranks #278 among its holdings.

1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Summitry LLC held 661 shares of Elevance Health worth $256K as of Q2 2026.
  • Elevance Health was a new Summitry LLC position in Q2 2026.
  • Elevance Health made up 0.01% of Summitry LLC's portfolio in Q2 2026, its #278 holding.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.